A detailed history of Aqr Capital Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 254,658 shares of EXAS stock, worth $15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
254,658
Previous 153,598 65.8%
Holding current value
$15 Million
Previous $6.49 Million 167.21%
% of portfolio
0.02%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$42.43 - $70.83 $4.29 Million - $7.16 Million
101,060 Added 65.8%
254,658 $17.3 Million
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $16.5 Million - $29.7 Million
-399,558 Reduced 72.23%
153,598 $6.49 Million
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $4.97 Million - $6.51 Million
-88,271 Reduced 13.76%
553,156 $38.2 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $18.5 Million - $23.7 Million
313,110 Added 95.37%
641,427 $47.5 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $13.7 Million - $20.6 Million
207,623 Added 172.02%
328,317 $22.4 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $7.23 Million - $11 Million
115,346 Added 2156.81%
120,694 $11.3 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $252,372 - $378,477
5,348 New
5,348 $362,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $290,507 - $403,424
-4,007 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $905,317 - $1.35 Million
-9,666 Reduced 70.69%
4,007 $498,000
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $256,220 - $340,711
2,198 Added 19.15%
13,673 $1.76 Million
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $793,393 - $1.13 Million
7,965 Added 226.92%
11,475 $1.52 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $124,401 - $174,029
-1,706 Reduced 32.71%
3,510 $357,000
Q2 2020

Aug 17, 2020

SELL
$55.75 - $92.75 $512,509 - $852,650
-9,193 Reduced 63.8%
5,216 $446,000
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $59,086 - $162,821
-1,559 Reduced 9.76%
14,409 $836,000
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $659,488 - $846,992
-8,492 Reduced 34.72%
15,968 $1.47 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $65,789 - $89,172
728 Added 3.07%
24,460 $2.21 Million
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $3.34 Million - $4.4 Million
-37,274 Reduced 61.1%
23,732 $2.8 Million
Q1 2019

May 14, 2019

BUY
$61.98 - $96.5 $2.8 Million - $4.35 Million
45,118 Added 283.98%
61,006 $5.28 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $657,069 - $969,188
-11,725 Reduced 42.46%
15,888 $1 Million
Q3 2018

Nov 15, 2018

SELL
$48.29 - $80.6 $1.36 Million - $2.27 Million
-28,224 Reduced 50.55%
27,613 $2.18 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $5.67 Million - $10.5 Million
-149,906 Reduced 72.86%
55,837 $3.34 Million
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $255,086 - $368,537
6,406 Added 3.21%
205,743 $8.3 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $660,901 - $860,210
-14,216 Reduced 6.66%
199,337 $10.5 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $7.91 Million - $10.1 Million
213,553
213,553 $10.1 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.